# EDGAR Filing Document

**Accession Number:** 0000778108
**File Stem:** 0000940400-26-008224
**Filing Date:** 2026-2
**Character Count:** 61565
**Document Hash:** 83f8fadc892fc213a613123f1b926b93
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000940400-26-008224.hdr.sgml**: 20260226

**ACCESSION NUMBER**: 0000940400-26-008224

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260226

**DATE AS OF CHANGE**: 20260226

**PERIOD START**: 20260331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DELAWARE GROUP EQUITY FUNDS IV
- **CENTRAL INDEX KEY:** 0000778108

**ORGANIZATION NAME:**
- **EIN:** 232369628
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-04413
- **FILM NUMBER:** 26683543

**BUSINESS ADDRESS:**
- **STREET 1:** 100 INDEPENDENCE
- **STREET 2:** 610 MARKET STREET
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19106-2354
- **BUSINESS PHONE:** 18005231918

**MAIL ADDRESS:**
- **STREET 1:** 100 INDEPENDENCE
- **STREET 2:** 610 MARKET STREET
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19106-2354

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DELAWARE GROUP EQUITY FUNDS IV INC
- **DATE OF NAME CHANGE:** 19970128

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DELAWARE GROUP DELCAP FUND INC
- **DATE OF NAME CHANGE:** 19920703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DELCAP FUND INC
- **DATE OF NAME CHANGE:** 19880929

## Series and Classes Contracts Data

### Nomura Healthcare Fund (Series ID: S000018873)

| Class ID   | Class Name          | Ticker Symbol   |
|:---|:---|:---|
| C000052257 | Class A             | DLHAX           |
| C000052258 | Class C             | DLHCX           |
| C000052259 | Class R             | DLRHX           |
| C000052260 | INSTITUTIONAL CLASS | DLHIX           |

## Nport-Ex

Schedule of investments

Nomura Healthcare Fund December 31, 2025 (Unaudited)

---

| | | |
|:---|:---|:---|
|  | Number of<br> shares | &nbsp;&nbsp;Value (US $) |
| &nbsp;&nbsp;**Common Stocks — 99.67%♣** | &nbsp;&nbsp;**Common Stocks — 99.67%♣** | &nbsp;&nbsp;**Common Stocks — 99.67%♣** |
| &nbsp;&nbsp;Biotechnology — 44.43% | &nbsp;&nbsp;Biotechnology — 44.43% | &nbsp;&nbsp;Biotechnology — 44.43% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AbbVie | &nbsp;&nbsp;&nbsp;&nbsp;125000 | &nbsp;&nbsp;$28561250 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abivax ADR † | &nbsp;&nbsp;&nbsp;&nbsp;45000 | &nbsp;&nbsp;&nbsp;&nbsp; 6068475 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ACADIA Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;92648 | &nbsp;&nbsp;&nbsp;&nbsp; 2474628 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Akero Therapeutics =, † | &nbsp;&nbsp;&nbsp;&nbsp;25000 | &nbsp;&nbsp;&nbsp;&nbsp; 16250 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Alkermes † | &nbsp;&nbsp;&nbsp;&nbsp;290000 | &nbsp;&nbsp;&nbsp;&nbsp; 8114200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Allogene Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;146779 | &nbsp;&nbsp;&nbsp;&nbsp; 201087 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Alnylam Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;30000 | &nbsp;&nbsp;&nbsp;&nbsp; 11929500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Altimmune † | &nbsp;&nbsp;&nbsp;&nbsp;100000 | &nbsp;&nbsp;&nbsp;&nbsp; 361000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amarin ADR † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9500 | &nbsp;&nbsp;&nbsp;&nbsp; 132573 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amgen | &nbsp;&nbsp;&nbsp;&nbsp;58000 | &nbsp;&nbsp;&nbsp;&nbsp; 18983980 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AnaptysBio † | &nbsp;&nbsp;&nbsp;&nbsp;93732 | &nbsp;&nbsp;&nbsp;&nbsp; 4544127 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Arcus Biosciences † | &nbsp;&nbsp;&nbsp;&nbsp;379100 | &nbsp;&nbsp;&nbsp;&nbsp; 9033953 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Biogen † | &nbsp;&nbsp;&nbsp;&nbsp;28000 | &nbsp;&nbsp;&nbsp;&nbsp; 4927720 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BioMarin Pharmaceutical † | &nbsp;&nbsp;&nbsp;&nbsp;100000 | &nbsp;&nbsp;&nbsp;&nbsp; 5943000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BioNTech ADR † | &nbsp;&nbsp;&nbsp;&nbsp;18000 | &nbsp;&nbsp;&nbsp;&nbsp; 1713600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cellectis ADR † | &nbsp;&nbsp;&nbsp;&nbsp;226875 | &nbsp;&nbsp;&nbsp;&nbsp; 1098075 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cogent Biosciences † | &nbsp;&nbsp;&nbsp;&nbsp;230000 | &nbsp;&nbsp;&nbsp;&nbsp; 8169600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coherus Oncology † | &nbsp;&nbsp;&nbsp;&nbsp;900000 | &nbsp;&nbsp;&nbsp;&nbsp; 1278000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compugen † | 1020000 | &nbsp;&nbsp;&nbsp;&nbsp; 1560600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cytokinetics † | &nbsp;&nbsp;&nbsp;&nbsp;15000 | &nbsp;&nbsp;&nbsp;&nbsp; 953100 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Day One Biopharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;110000 | &nbsp;&nbsp;&nbsp;&nbsp; 1025200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dynavax Technologies † | &nbsp;&nbsp;&nbsp;&nbsp;570000 | &nbsp;&nbsp;&nbsp;&nbsp; 8766600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exact Sciences † | &nbsp;&nbsp;&nbsp;&nbsp;33000 | &nbsp;&nbsp;&nbsp;&nbsp; 3351480 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fortress Biotech † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6666 | &nbsp;&nbsp;&nbsp;&nbsp; 24398 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Galmed Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1701 | &nbsp;&nbsp;&nbsp;&nbsp; 1277 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gilead Sciences | &nbsp;&nbsp;&nbsp;&nbsp;210000 | &nbsp;&nbsp;&nbsp;&nbsp; 25775400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;GRAIL † | &nbsp;&nbsp;&nbsp;&nbsp;80000 | &nbsp;&nbsp;&nbsp;&nbsp; 6847200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Halozyme Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;220000 | &nbsp;&nbsp;&nbsp;&nbsp; 14806000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Immunovant † | &nbsp;&nbsp;&nbsp;&nbsp;122100 | &nbsp;&nbsp;&nbsp;&nbsp; 3103782 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incyte † | &nbsp;&nbsp;&nbsp;&nbsp;80000 | &nbsp;&nbsp;&nbsp;&nbsp; 7901600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;InnoCare Pharma Class H 144A #, † | &nbsp;&nbsp;&nbsp;&nbsp;17000 | &nbsp;&nbsp;&nbsp;&nbsp; 26887 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Instil Bio † | &nbsp;&nbsp;&nbsp;&nbsp;50000 | &nbsp;&nbsp;&nbsp;&nbsp; 550000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intellia Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;20000 | &nbsp;&nbsp;&nbsp;&nbsp; 179800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Janux Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;76601 | &nbsp;&nbsp;&nbsp;&nbsp; 1057094 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Karyopharm Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;33333 | &nbsp;&nbsp;&nbsp;&nbsp; 245331 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Life Strategy † | &nbsp;&nbsp;&nbsp;&nbsp;30000 | &nbsp;&nbsp;&nbsp;&nbsp; 39600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MacroGenics † | &nbsp;&nbsp;&nbsp;&nbsp;420000 | &nbsp;&nbsp;&nbsp;&nbsp; 676200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Madrigal Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7000 | &nbsp;&nbsp;&nbsp;&nbsp; 4076380 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Moderna † | &nbsp;&nbsp;&nbsp;&nbsp;20000 | &nbsp;&nbsp;&nbsp;&nbsp; 589800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Monte Rosa Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;200000 | &nbsp;&nbsp;&nbsp;&nbsp; 3136000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MoonLake Immunotherapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;80000 | &nbsp;&nbsp;&nbsp;&nbsp; 1054400 |

---

NQ- 573 [1225] 0226 (5191634) 1

------

Schedule of investments

Nomura Healthcare Fund

---

| | | |
|:---|:---|:---|
|  | Number of<br> shares | &nbsp;&nbsp;Value (US $) |
| &nbsp;&nbsp;**Common Stocks♣ (continued)** | &nbsp;&nbsp;**Common Stocks♣ (continued)** | &nbsp;&nbsp;**Common Stocks♣ (continued)** |
| &nbsp;&nbsp;Biotechnology (continued) | &nbsp;&nbsp;Biotechnology (continued) | &nbsp;&nbsp;Biotechnology (continued) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mustang Bio † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;160 | &nbsp;&nbsp;$157 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Myriad Genetics † | &nbsp;&nbsp;&nbsp;&nbsp;50000 | &nbsp;&nbsp;&nbsp;&nbsp; 307500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neurocrine Biosciences † | &nbsp;&nbsp;&nbsp;&nbsp;70000 | &nbsp;&nbsp;&nbsp;&nbsp; 9928100 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NextCure † | &nbsp;&nbsp;&nbsp;&nbsp;12500 | &nbsp;&nbsp;&nbsp;&nbsp; 177375 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Olema Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;50000 | &nbsp;&nbsp;&nbsp;&nbsp; 1250000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Phio Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;50000 | &nbsp;&nbsp;&nbsp;&nbsp; 52500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ProQR Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;620000 | &nbsp;&nbsp;&nbsp;&nbsp; 1252400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Puma Biotechnology † | &nbsp;&nbsp;&nbsp;&nbsp;61255 | &nbsp;&nbsp;&nbsp;&nbsp; 364467 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Regeneron Pharmaceuticals | &nbsp;&nbsp;&nbsp;&nbsp;47000 | &nbsp;&nbsp;&nbsp;&nbsp; 36277890 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;REGENXBIO † | &nbsp;&nbsp;&nbsp;&nbsp;149000 | &nbsp;&nbsp;&nbsp;&nbsp; 2145600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rigel Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;160000 | &nbsp;&nbsp;&nbsp;&nbsp; 6852800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rocket Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;58000 | &nbsp;&nbsp;&nbsp;&nbsp; 203580 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Roivant Sciences † | &nbsp;&nbsp;&nbsp;&nbsp;338181 | &nbsp;&nbsp;&nbsp;&nbsp; 7338528 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sangamo Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;400000 | &nbsp;&nbsp;&nbsp;&nbsp; 168000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sarepta Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;11000 | &nbsp;&nbsp;&nbsp;&nbsp; 236720 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sio Gene Therapies † | &nbsp;&nbsp;&nbsp;&nbsp;64171 | &nbsp;&nbsp;&nbsp;&nbsp; 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Syndax Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;180000 | &nbsp;&nbsp;&nbsp;&nbsp; 3781800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ultragenyx Pharmaceutical † | &nbsp;&nbsp;&nbsp;&nbsp;70000 | &nbsp;&nbsp;&nbsp;&nbsp; 1610000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;uniQure † | &nbsp;&nbsp;&nbsp;&nbsp;258211 | &nbsp;&nbsp;&nbsp;&nbsp; 6178989 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;United Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3000 | &nbsp;&nbsp;&nbsp;&nbsp; 1461750 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Vaxcyte † | &nbsp;&nbsp;&nbsp;&nbsp;20000 | &nbsp;&nbsp;&nbsp;&nbsp; 922800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Vertex Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;25000 | &nbsp;&nbsp;&nbsp;&nbsp; 11334000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Viking Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;330100 | &nbsp;&nbsp;&nbsp;&nbsp; 11612918 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Vir Biotechnology † | &nbsp;&nbsp;&nbsp;&nbsp;220000 | &nbsp;&nbsp;&nbsp;&nbsp; 1326600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Viridian Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;29370 | &nbsp;&nbsp;&nbsp;&nbsp; 913994 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Voyager Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5700 | &nbsp;&nbsp;&nbsp;&nbsp; 22401 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Xencor † | &nbsp;&nbsp;&nbsp;&nbsp;200000 | &nbsp;&nbsp;&nbsp;&nbsp; 3062000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;XOMA Royalty † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3466 | &nbsp;&nbsp;&nbsp;&nbsp; 92161 |
|  |  | &nbsp;&nbsp;&nbsp;308174177 |
| &nbsp;&nbsp;Commercial & Residential Mortgage — 3.55% | &nbsp;&nbsp;Commercial & Residential Mortgage — 3.55% | &nbsp;&nbsp;Commercial & Residential Mortgage — 3.55% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fannie Mae † | 1300000 | &nbsp;&nbsp;&nbsp;&nbsp; 13949000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Federal Home Loan Mortgage † | 1050000 | &nbsp;&nbsp;&nbsp;&nbsp; 10647000 |
|  |  | &nbsp;&nbsp;&nbsp; 24596000 |
| &nbsp;&nbsp;Healthcare Equipment — 5.23% | &nbsp;&nbsp;Healthcare Equipment — 5.23% | &nbsp;&nbsp;Healthcare Equipment — 5.23% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Boston Scientific † | &nbsp;&nbsp;&nbsp;&nbsp;250000 | &nbsp;&nbsp;&nbsp;&nbsp; 23837500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stryker | &nbsp;&nbsp;&nbsp;&nbsp;15000 | &nbsp;&nbsp;&nbsp;&nbsp; 5272050 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Zimmer Biomet Holdings | &nbsp;&nbsp;&nbsp;&nbsp;80000 | &nbsp;&nbsp;&nbsp;&nbsp; 7193600 |
|  |  | &nbsp;&nbsp;&nbsp; 36303150 |

---

2 NQ- 573 [1225] 0226 (5191634)

------

---

| | | |
|:---|:---|:---|
|  | Number of<br> shares | &nbsp;&nbsp;Value (US $) |
| &nbsp;&nbsp;**Common Stocks♣ (continued)** | &nbsp;&nbsp;**Common Stocks♣ (continued)** | &nbsp;&nbsp;**Common Stocks♣ (continued)** |
| &nbsp;&nbsp;Healthcare Services — 1.61% | &nbsp;&nbsp;Healthcare Services — 1.61% | &nbsp;&nbsp;Healthcare Services — 1.61% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CVS Health | &nbsp;&nbsp;&nbsp;&nbsp;75000 | &nbsp;&nbsp;$5952000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Quest Diagnostics | &nbsp;&nbsp;&nbsp;&nbsp;30000 | &nbsp;&nbsp;&nbsp;&nbsp; 5205900 |
|  |  | &nbsp;&nbsp;&nbsp; 11157900 |
| &nbsp;&nbsp;Life Sciences Tools & Services — 1.70% | &nbsp;&nbsp;Life Sciences Tools & Services — 1.70% | &nbsp;&nbsp;Life Sciences Tools & Services — 1.70% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Illumina † | &nbsp;&nbsp;&nbsp;&nbsp;90000 | &nbsp;&nbsp;&nbsp;&nbsp; 11804400 |
|  |  | &nbsp;&nbsp;&nbsp; 11804400 |
| &nbsp;&nbsp;Managed Healthcare — 6.52% | &nbsp;&nbsp;Managed Healthcare — 6.52% | &nbsp;&nbsp;Managed Healthcare — 6.52% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Elevance Health | &nbsp;&nbsp;&nbsp;&nbsp;63000 | &nbsp;&nbsp;&nbsp;&nbsp; 22084650 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;UnitedHealth Group | &nbsp;&nbsp;&nbsp;&nbsp;70000 | &nbsp;&nbsp;&nbsp;&nbsp; 23107700 |
|  |  | &nbsp;&nbsp;&nbsp; 45192350 |
| &nbsp;&nbsp;Pharmaceuticals — 36.63% | &nbsp;&nbsp;Pharmaceuticals — 36.63% | &nbsp;&nbsp;Pharmaceuticals — 36.63% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Arvinas † | &nbsp;&nbsp;&nbsp;&nbsp;180000 | &nbsp;&nbsp;&nbsp;&nbsp; 2134800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AstraZeneca | &nbsp;&nbsp;&nbsp;&nbsp;131243 | &nbsp;&nbsp;&nbsp;&nbsp; 24287744 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Atea Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;70000 | &nbsp;&nbsp;&nbsp;&nbsp; 249900 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chugai Pharmaceutical | &nbsp;&nbsp;&nbsp;&nbsp;450000 | &nbsp;&nbsp;&nbsp;&nbsp; 23607706 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;COSMO Pharmaceuticals | &nbsp;&nbsp;&nbsp;&nbsp;14000 | &nbsp;&nbsp;&nbsp;&nbsp; 1843942 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Eli Lilly & Co. | &nbsp;&nbsp;&nbsp;&nbsp;28000 | &nbsp;&nbsp;&nbsp;&nbsp; 30091040 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Euroapi † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8695 | &nbsp;&nbsp;&nbsp;&nbsp; 23139 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Johnson & Johnson | &nbsp;&nbsp;&nbsp;&nbsp;20000 | &nbsp;&nbsp;&nbsp;&nbsp; 4139000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Landos Biopharma † | &nbsp;&nbsp;&nbsp;&nbsp;14718 | &nbsp;&nbsp;&nbsp;&nbsp; 36942 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Merck & Co. | &nbsp;&nbsp;&nbsp;&nbsp;270000 | &nbsp;&nbsp;&nbsp;&nbsp; 28420200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nektar Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;17092 | &nbsp;&nbsp;&nbsp;&nbsp; 722650 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Organon & Co. | &nbsp;&nbsp;&nbsp;&nbsp;29500 | &nbsp;&nbsp;&nbsp;&nbsp; 211515 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Perrigo | &nbsp;&nbsp;&nbsp;&nbsp;230000 | &nbsp;&nbsp;&nbsp;&nbsp; 3201600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pfizer | 1145000 | &nbsp;&nbsp;&nbsp;&nbsp; 28510500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Roche Holding | &nbsp;&nbsp;&nbsp;&nbsp;55000 | &nbsp;&nbsp;&nbsp;&nbsp; 22713365 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sanofi | &nbsp;&nbsp;&nbsp;&nbsp;120000 | &nbsp;&nbsp;&nbsp;&nbsp; 11610627 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Structure Therapeutics ADR † | &nbsp;&nbsp;&nbsp;&nbsp;58000 | &nbsp;&nbsp;&nbsp;&nbsp; 4033900 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tarsus Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;100000 | &nbsp;&nbsp;&nbsp;&nbsp; 8188000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Theravance Biopharma † | &nbsp;&nbsp;&nbsp;&nbsp;208783 | &nbsp;&nbsp;&nbsp;&nbsp; 3906330 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;UCB | &nbsp;&nbsp;&nbsp;&nbsp;130137 | &nbsp;&nbsp;&nbsp;&nbsp; 36259629 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ventyx Biosciences † | &nbsp;&nbsp;&nbsp;&nbsp;430000 | &nbsp;&nbsp;&nbsp;&nbsp; 3882900 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Viatris | 1170018 | &nbsp;&nbsp;&nbsp;&nbsp; 14566724 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WaVe Life Sciences † | &nbsp;&nbsp;&nbsp;&nbsp;81955 | &nbsp;&nbsp;&nbsp;&nbsp; 1393235 |
|  |  | &nbsp;&nbsp;&nbsp;254035388 |
| &nbsp;&nbsp;&nbsp;**Total Common Stocks (cost $466,540,331)** | &nbsp;&nbsp;&nbsp;**Total Common Stocks (cost $466,540,331)** | &nbsp;&nbsp;&nbsp;**691263365** |

---

NQ- 573 [1225] 0226 (5191634) 3

------

Schedule of investments

Nomura Healthcare Fund

---

| | | |
|:---|:---|:---|
|  | Number of<br> shares | &nbsp;&nbsp;Value (US $) |
| &nbsp;&nbsp;**Rights — 0.01%♣** | &nbsp;&nbsp;**Rights — 0.01%♣** | &nbsp;&nbsp;**Rights — 0.01%♣** |
| &nbsp;&nbsp;Biotechnology — 0.01% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ambit Bioscience =, †, π | &nbsp;&nbsp;&nbsp;&nbsp;76500 | &nbsp;&nbsp;$0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contra Surface Oncolog † | &nbsp;&nbsp;&nbsp;&nbsp;350000 | &nbsp;&nbsp;&nbsp;&nbsp; 26950 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mirati Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;60000 | &nbsp;&nbsp;&nbsp;&nbsp; 42000 |
| &nbsp;&nbsp;&nbsp;**Total Rights (cost $0)** | &nbsp;&nbsp;&nbsp;**Total Rights (cost $0)** | &nbsp;&nbsp;&nbsp; **68950** |
| &nbsp;&nbsp;**Short-Term Investments — 0.10%** | &nbsp;&nbsp;**Short-Term Investments — 0.10%** | &nbsp;&nbsp;**Short-Term Investments — 0.10%** |
| &nbsp;&nbsp;Money Market Mutual Funds — 0.10% | &nbsp;&nbsp;Money Market Mutual Funds — 0.10% | &nbsp;&nbsp;Money Market Mutual Funds — 0.10% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund – Institutional Shares (seven-day effective yield 3.65%) | &nbsp;&nbsp;&nbsp;&nbsp;166517 | &nbsp;&nbsp;&nbsp;&nbsp; 166517 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money Market Government Portfolio – Class I (seven-day effective yield 3.67%) | &nbsp;&nbsp;&nbsp;&nbsp;166516 | &nbsp;&nbsp;&nbsp;&nbsp; 166516 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square Government Fund – Institutional Shares (seven-day effective yield 3.68%) | &nbsp;&nbsp;&nbsp;&nbsp;166516 | &nbsp;&nbsp;&nbsp;&nbsp; 166516 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional Liquidity Funds Government Portfolio – Institutional Class (seven-day effective yield 3.69%) | &nbsp;&nbsp;&nbsp;&nbsp;166516 | &nbsp;&nbsp;&nbsp;&nbsp; 166516 |
| &nbsp;&nbsp;&nbsp;**Total Short-Term Investments (cost $666,065)** | &nbsp;&nbsp;&nbsp;**Total Short-Term Investments (cost $666,065)** | &nbsp;&nbsp;&nbsp; **666065** |
| &nbsp;&nbsp;&nbsp;**Total Value of Securities—99.78%<br> (cost $467,206,396)** |  | &nbsp;&nbsp;&nbsp;&nbsp;**691998380** |
| &nbsp;&nbsp;&nbsp;**Receivables and Other Assets Net of Liabilities—0.22%** |  | &nbsp;&nbsp;&nbsp;&nbsp; **1535988** |
| &nbsp;&nbsp;&nbsp;**Net Assets Applicable to 26,547,116 Shares Outstanding—100.00%** |  | &nbsp;&nbsp;**$693534368** |

---

---

| |
|:---|
| Categorizations used for financial reporting purposes may differ from categorizations used for regulatory compliance and/or internal classification purposes. |
| Non-income producing security. |
| The value of this security was determined using significant unobservable inputs and is reported as a Level 3 security. |
| Security exempt from registration under Rule 144A of the Securities Act of 1933, as amended. At December 31, 2025, the aggregate value of Rule 144A securities was $26,887, which represented less than 0.01% of the Fund's net assets. |
| Restricted security. These investments are in securities not registered under the Securities Act of 1933, as amended, and have certain restrictions on resale which may limit their liquidity. At December 31, 2025, the aggregate value of restricted securities was $0, which represented 0.00% of the Fund's net assets. See table below for additional details on restricted securities. |

---

4 NQ- 573 [1225] 0226 (5191634)

------

---

| | | | |
|:---|:---|:---|:---|
| **Restricted Securities** |  |  |  |
| Investments | &nbsp;&nbsp;Date of Acquisition | &nbsp;&nbsp;Cost | &nbsp;&nbsp;Value |
| Ambit Bioscience | &nbsp;&nbsp;11/12/14 | &nbsp;&nbsp;$0 | &nbsp;&nbsp;$0 |

---

---

| |
|:---|
| **Summary of abbreviations:** |
| ADR – American Depositary Receipt |

---

NQ- 573 [1225] 0226 (5191634) 5

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Delaware Group Equity Funds IV

- **b. Investment Company Act file number:** 811-04413

- **c. CIK number of Registrant:** 0000778108

- **d. LEI of Registrant:** 549300OT9UDUW3MXT836

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 100 Independence

  - **City:** Philadelphia

  - **State:** PA

  - **Foreign country:** US

  - **Zip / Postal Code:** 19106-2354

  - **Telephone number:** 800-523-1918

**Item A.2. Information about the Series.**

- **a. Name of Series:** Nomura Healthcare Fund

- **b. EDGAR series identifier (if any):** S000018873

- **c. LEI of Series:** 3T01W8DZEUUPS0D3VS95

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-03-31

- **b. Date as of which information is reported:** 2025-12-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $697198205.24

**Total Liabilities:** $3566080.35

**Net Assets:** $693632124.89

**Cash Not Reported:** $709970.18

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000052257 | 5.09%                | 8.43%                | -1.17%               |
| Class ID C000052258 | 5.04%                | 8.34%                | -1.21%               |
| Class ID C000052259 | 5.10%                | 8.36%                | -1.17%               |
| Class ID C000052260 | 5.10%                | 8.43%                | -1.14%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $7329888.53              | $26593822.79                               |
| Month 2  | $8471753.20              | $48059044.88                               |
| Month 3  | $8012272.82              | $-17234915.11                              |

### Schedule of Portfolio Investments

| Name                                           | Title                                          | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Monte Rosa Therapeutics Inc                    | Monte Rosa Therapeutics Inc                    | CUSIP: 61225M102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    200000 | NS      | $3136000.00   | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Coherus Oncology Inc                           | Coherus Oncology Inc                           | CUSIP: 19249H103<br>LEI: 5493007IL8W5MV932D26 | Long             | EC               | CORP              | US        |    900000 | NS      | $1278000.00   | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Theravance Biopharma Inc                       | Theravance Biopharma Inc                       | CUSIP: 000000000<br>LEI: 5493007VTSXP4Z6MIW52 | Long             | EC               | CORP              | KY        |    208783 | NS      | $3906329.93   | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| ACADIA Pharmaceuticals Inc                     | ACADIA Pharmaceuticals Inc                     | CUSIP: 004225108<br>LEI: 529900O3044NO0PEA039 | Long             | EC               | CORP              | US        |     92648 | NS      | $2474628.08   | 0.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Cytokinetics Inc                               | Cytokinetics Inc                               | CUSIP: 23282W605<br>LEI: 549300BE5DY1HW7IHA64 | Long             | EC               | CORP              | US        |     15000 | NS      | $953100.00    | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| BlackRock Liquidity FedFund                    | BlackRock Liquidity FedFund                    | CUSIP: 09248U700<br>LEI: 549300T8K043VZEOVK74 | Long             | STIV             | RF                | US        |    166516 | NS      | $166516.40    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Compugen Ltd                                   | Compugen Ltd                                   | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | IL        |   1020000 | NS      | $1560600.00   | 0.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                              | Johnson & Johnson                              | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |     20000 | NS      | $4139000.00   | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie Inc                                     | AbbVie Inc                                     | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |    125000 | NS      | $28561250.00  | 4.12%             |  |  |  | No            |                  1 | On Loan: No      |
| ProQR Therapeutics NV                          | ProQR Therapeutics NV                          | CUSIP: 000000000<br>LEI: 549300NGS2FJGGDBGS06 | Long             | EC               | CORP              | NL        |    620000 | NS      | $1252400.00   | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Voyager Therapeutics Inc                       | Voyager Therapeutics Inc                       | CUSIP: 92915B106<br>LEI: 54930082S4XVR0ZWCC74 | Long             | EC               | CORP              | US        |      5700 | NS      | $22401.00     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Sarepta Therapeutics Inc                       | Sarepta Therapeutics Inc                       | CUSIP: 803607100<br>LEI: 549300IKDPIED8J8IG21 | Long             | EC               | CORP              | US        |     11000 | NS      | $236720.00    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Vaxcyte Inc                                    | Vaxcyte Inc                                    | CUSIP: 92243G108<br>LEI: 254900M7NMHTGASX8D95 | Long             | EC               | CORP              | US        |     20000 | NS      | $922800.00    | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcus Biosciences Inc                          | Arcus Biosciences Inc                          | CUSIP: 03969F109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    379100 | NS      | $9033953.00   | 1.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Structure Therapeutics Inc                     | Structure Therapeutics Inc                     | CUSIP: 86366E106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     58000 | NS      | $4033900.00   | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Quest Diagnostics Inc                          | Quest Diagnostics Inc                          | CUSIP: 74834L100<br>LEI: 8MCWUBXQ0WE04KMXBX50 | Long             | EC               | CORP              | US        |     30000 | NS      | $5205900.00   | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Incyte Corp                                    | Incyte Corp                                    | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |     80000 | NS      | $7901600.00   | 1.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurocrine Biosciences Inc                     | Neurocrine Biosciences Inc                     | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |     70000 | NS      | $9928100.00   | 1.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Instil Bio Inc                                 | Instil Bio Inc                                 | CUSIP: 45783C200<br>LEI: 529900HW1XOEQEVG5T88 | Long             | EC               | CORP              | US        |     50000 | NS      | $550000.00    | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Boston Scientific Corp                         | Boston Scientific Corp                         | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |    250000 | NS      | $23837500.00  | 3.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Contra Surface Oncolog                         | Contra Surface Oncolog                         | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    350000 | NS      | $26950.00     | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| Roivant Sciences Ltd                           | Roivant Sciences Ltd                           | CUSIP: 000000000<br>LEI: 549300DL466NY5J6U724 | Long             | EC               | CORP              | US        |    338181 | NS      | $7338527.70   | 1.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Cellectis SA                                   | Cellectis SA                                   | CUSIP: 15117K103<br>LEI: 5493000KKX5VQ37Q2W83 | Long             | EC               | CORP              | FR        |    226875 | NS      | $1098075.00   | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Amarin Corp PLC                                | Amarin Corp PLC                                | CUSIP: 023111404<br>LEI: 5493009JFIGUFEVPK217 | Long             | EC               | CORP              | IE        |      9500 | NS      | $132572.50    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| COSMO Pharmaceuticals NV                       | COSMO Pharmaceuticals NV                       | CUSIP: 000000000<br>LEI: 724500OX0EBQRYTVV639 | Long             | EC               | CORP              | IE        |     14000 | NS      | $1843941.87   | 0.27%             |  |  |  | No            |                  2 | On Loan: No      |
| NextCure Inc                                   | NextCure Inc                                   | CUSIP: 65343E207<br>LEI: 549300Y5PR6RJR1STI24 | Long             | EC               | CORP              | US        |     12500 | NS      | $177375.00    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| LANDOS BIOPHARMA INC                           | LANDOS BIOPHARMA INC                           | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14718 | NS      | $36942.18     | 0.01%             |  |  |  | No            |                  2 | On Loan: No      |
| Lite Strategy Inc                              | Lite Strategy Inc                              | CUSIP: 55279B301<br>LEI: 529900A43X33ON524197 | Long             | EC               | CORP              | US        |     30000 | NS      | $39600.00     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Tarsus Pharmaceuticals Inc                     | Tarsus Pharmaceuticals Inc                     | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    100000 | NS      | $8188000.00   | 1.18%             |  |  |  | No            |                  1 | On Loan: No      |
| uniQure NV                                     | uniQure NV                                     | CUSIP: 000000000<br>LEI: 724500RPCTZLFYJZ3S98 | Long             | EC               | CORP              | NL        |    258211 | NS      | $6178989.23   | 0.89%             |  |  |  | No            |                  1 | On Loan: No      |
| MacroGenics Inc                                | MacroGenics Inc                                | CUSIP: 556099109<br>LEI: 5493001KJQUA83L8MH79 | Long             | EC               | CORP              | US        |    420000 | NS      | $676200.00    | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Myriad Genetics Inc                            | Myriad Genetics Inc                            | CUSIP: 62855J104<br>LEI: 52990044IHUOUMETT163 | Long             | EC               | CORP              | US        |     50000 | NS      | $307500.00    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                                 | Eli Lilly & Co                                 | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |     28000 | NS      | $30091040.00  | 4.34%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc                         | UnitedHealth Group Inc                         | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |     70000 | NS      | $23107700.00  | 3.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Viatris Inc                                    | Viatris Inc                                    | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |   1170018 | NS      | $14566724.10  | 2.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Chugai Pharmaceutical Co Ltd                   | Chugai Pharmaceutical Co Ltd                   | CUSIP: 000000000<br>LEI: 529900T9LAII161DCN95 | Long             | EC               | CORP              | JP        |    450000 | NS      | $23607706.25  | 3.40%             |  |  |  | No            |                  2 | On Loan: No      |
| Janux Therapeutics Inc                         | Janux Therapeutics Inc                         | CUSIP: 47103J105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     76601 | NS      | $1057093.80   | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Pfizer Inc                                     | Pfizer Inc                                     | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |   1145000 | NS      | $28510500.00  | 4.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Sanofi SA                                      | Sanofi SA                                      | CUSIP: 000000000<br>LEI: 549300E9PC51EN656011 | Long             | EC               | CORP              | FR        |    120000 | NS      | $11610627.20  | 1.67%             |  |  |  | No            |                  2 | On Loan: No      |
| Xencor Inc                                     | Xencor Inc                                     | CUSIP: 98401F105<br>LEI: 549300V5IF65437JKG30 | Long             | EC               | CORP              | US        |    200000 | NS      | $3062000.00   | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Rocket Pharmaceuticals Inc                     | Rocket Pharmaceuticals Inc                     | CUSIP: 77313F106<br>LEI: 549300R7VV82YUIN4Y93 | Long             | EC               | CORP              | US        |     58000 | NS      | $203580.00    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc                                      | Amgen Inc                                      | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |     58000 | NS      | $18983980.00  | 2.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Abivax SA                                      | Abivax SA                                      | CUSIP: 00370M103<br>LEI: 969500D8TMNB184OJU95 | Long             | EC               | CORP              | FR        |     45000 | NS      | $6068475.00   | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Intellia Therapeutics Inc                      | Intellia Therapeutics Inc                      | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               | CORP              | US        |     20000 | NS      | $179800.00    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Alnylam Pharmaceuticals Inc                    | Alnylam Pharmaceuticals Inc                    | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               | CORP              | US        |     30000 | NS      | $11929500.00  | 1.72%             |  |  |  | No            |                  1 | On Loan: No      |
| UCB SA                                         | UCB SA                                         | CUSIP: 000000000<br>LEI: 2138008J191VLSGY5A09 | Long             | EC               | CORP              | BE        |    130137 | NS      | $36259628.96  | 5.23%             |  |  |  | No            |                  2 | On Loan: No      |
| Arvinas Inc                                    | Arvinas Inc                                    | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    180000 | NS      | $2134800.00   | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Altimmune Inc                                  | Altimmune Inc                                  | CUSIP: 02155H200<br>LEI: 549300EOYCQ8SW3NVE64 | Long             | EC               | CORP              | US        |    100000 | NS      | $361000.00    | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Euroapi SA                                     | Euroapi SA                                     | CUSIP: 000000000<br>LEI: 9695002FT7GGI3CKKJ14 | Long             | EC               | CORP              | FR        |      8695 | NS      | $23138.27     | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| Fidelity Government Portfolio                  | Fidelity Government Portfolio                  | CUSIP: 316175108<br>LEI: 549300FQDFZGLUOCWN51 | Long             | STIV             | RF                | US        |    166516 | NS      | $166516.34    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| MoonLake Immunotherapeutics                    | MoonLake Immunotherapeutics                    | CUSIP: 61559X104<br>LEI: N/A                  | Long             | EC               | CORP              | CH        |     80000 | NS      | $1054400.00   | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Zimmer Biomet Holdings Inc                     | Zimmer Biomet Holdings Inc                     | CUSIP: 98956P102<br>LEI: 2P2YLDVPES3BXQ1FRB91 | Long             | EC               | CORP              | US        |     80000 | NS      | $7193600.00   | 1.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Biogen Inc                                     | Biogen Inc                                     | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |     28000 | NS      | $4927720.00   | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| United Therapeutics Corp                       | United Therapeutics Corp                       | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |      3000 | NS      | $1461750.00   | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Exact Sciences Corp                            | Exact Sciences Corp                            | CUSIP: 30063P105<br>LEI: 549300VM3X1FYD4N9Z14 | Long             | EC               | CORP              | US        |     33000 | NS      | $3351480.00   | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Cogent Biosciences Inc                         | Cogent Biosciences Inc                         | CUSIP: 19240Q201<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    230000 | NS      | $8169600.00   | 1.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Olema Pharmaceuticals Inc                      | Olema Pharmaceuticals Inc                      | CUSIP: 68062P106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     50000 | NS      | $1250000.00   | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Sangamo Therapeutics Inc                       | Sangamo Therapeutics Inc                       | CUSIP: 800677106<br>LEI: 2549006WMRKRC4G32Z67 | Long             | EC               | CORP              | US        |    400000 | NS      | $168000.00    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co Inc                                 | Merck & Co Inc                                 | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |    270000 | NS      | $28420200.00  | 4.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Ventyx Biosciences Inc                         | Ventyx Biosciences Inc                         | CUSIP: 92332V107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    430000 | NS      | $3882900.00   | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Puma Biotechnology Inc                         | Puma Biotechnology Inc                         | CUSIP: 74587V107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     61255 | NS      | $364467.25    | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Freddie Mac                                    | Federal Home Loan Mortgage Corp                | CUSIP: 313400301<br>LEI: S6XOOCT0IEG5ABCC6L87 | Long             | EC               | USGSE             | US        |   1050000 | NS      | $10647000.00  | 1.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Roche Holding AG                               | Roche Holding AG                               | CUSIP: 000000000<br>LEI: 549300U41AUUVOAAOB37 | Long             | EC               | CORP              | CH        |     55000 | NS      | $22713365.21  | 3.27%             |  |  |  | No            |                  2 | On Loan: No      |
| Day One Biopharmaceuticals Inc                 | Day One Biopharmaceuticals Inc                 | CUSIP: 23954D109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    110000 | NS      | $1025200.00   | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Nektar Therapeutics                            | Nektar Therapeutics                            | CUSIP: 640268306<br>LEI: 5299005I24806IOIYE03 | Long             | EC               | CORP              | US        |     17092 | NS      | $722649.76    | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Akero Therapeutics Inc                         | Akero Therapeutics Inc                         | CUSIP: 00973Y108<br>LEI: 549300SI3KG74LBE2955 | Long             | EC               | CORP              | US        |     25000 | NS      | $16250.00     | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| Viridian Therapeutics Inc                      | Viridian Therapeutics Inc                      | CUSIP: 92790C104<br>LEI: 549300C775BNYF550E70 | Long             | EC               | CORP              | US        |     29370 | NS      | $913994.40    | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| BioMarin Pharmaceutical Inc                    | BioMarin Pharmaceutical Inc                    | CUSIP: 09061G101<br>LEI: NSLL8ITTRR0J5HEMR848 | Long             | EC               | CORP              | US        |    100000 | NS      | $5943000.00   | 0.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Ultragenyx Pharmaceutical Inc                  | Ultragenyx Pharmaceutical Inc                  | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               | CORP              | US        |     70000 | NS      | $1610000.00   | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Viking Therapeutics Inc                        | Viking Therapeutics Inc                        | CUSIP: 92686J106<br>LEI: 529900IVC72YPFA25M37 | Long             | EC               | CORP              | US        |    330100 | NS      | $11612918.00  | 1.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Perrigo Co PLC                                 | Perrigo Co PLC                                 | CUSIP: 000000000<br>LEI: 549300IFOQS6R1QLY196 | Long             | EC               | CORP              | IE        |    230000 | NS      | $3201600.00   | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Madrigal Pharmaceuticals Inc                   | Madrigal Pharmaceuticals Inc                   | CUSIP: 558868105<br>LEI: 549300CHIMT2EUSNJB60 | Long             | EC               | CORP              | US        |      7000 | NS      | $4076380.00   | 0.59%             |  |  |  | No            |                  1 | On Loan: No      |
| WaVe Life Sciences Ltd                         | WaVe Life Sciences Ltd                         | CUSIP: 000000000<br>LEI: 54930070006GPKFYZ813 | Long             | EC               | CORP              | SG        |     81955 | NS      | $1393235.00   | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| REGENXBIO Inc                                  | REGENXBIO Inc                                  | CUSIP: 75901B107<br>LEI: 549300EOES47LATSET33 | Long             | EC               | CORP              | US        |    149000 | NS      | $2145600.00   | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| GRAIL Inc                                      | GRAIL Inc                                      | CUSIP: 384747101<br>LEI: 2549009XSNESW3VE8024 | Long             | EC               | CORP              | US        |     80000 | NS      | $6847200.00   | 0.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Galmed Pharmaceuticals Ltd                     | Galmed Pharmaceuticals Ltd                     | CUSIP: 000000000<br>LEI: 549300FL07PJ8ICSMD04 | Long             | EC               | CORP              | IL        |      1701 | NS      | $1276.60      | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Rigel Pharmaceuticals Inc                      | Rigel Pharmaceuticals Inc                      | CUSIP: 766559702<br>LEI: 529900KPTNUS5J8K9K66 | Long             | EC               | CORP              | US        |    160000 | NS      | $6852800.00   | 0.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Organon & Co                                   | Organon & Co                                   | CUSIP: 68622V106<br>LEI: 549300AMCKY57OK2CO56 | Long             | EC               | CORP              | US        |     29500 | NS      | $211515.00    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Fortress Biotech Inc                           | Fortress Biotech Inc                           | CUSIP: 34960Q307<br>LEI: 529900DZUWSYUURECK24 | Long             | EC               | CORP              | US        |      6666 | NS      | $24397.56     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                                | AstraZeneca PLC                                | CUSIP: 000000000<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |    131243 | NS      | $24287743.99  | 3.50%             |  |  |  | No            |                  2 | On Loan: No      |
| Elevance Health Inc                            | Elevance Health Inc                            | CUSIP: 036752103<br>LEI: 8MYN82XMYQH89CTMTH67 | Long             | EC               | CORP              | US        |     63000 | NS      | $22084650.00  | 3.18%             |  |  |  | No            |                  1 | On Loan: No      |
| XOMA Royalty Corp                              | XOMA Royalty Corp                              | CUSIP: 98419J206<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3466 | NS      | $92160.94     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Alkermes PLC                                   | Alkermes PLC                                   | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | IE        |    290000 | NS      | $8114200.00   | 1.17%             |  |  |  | No            |                  1 | On Loan: No      |
| MIRATI THERAPEUTICS INC                        | MIRATI THERAPEUTICS INC                        | CUSIP: 604CVR027<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     60000 | NS      | $42000.00     | 0.01%             |  |  |  | No            |                  2 | On Loan: No      |
| Atea Pharmaceuticals Inc                       | Atea Pharmaceuticals Inc                       | CUSIP: 04683R106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     70000 | NS      | $249900.00    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Vir Biotechnology Inc                          | Vir Biotechnology Inc                          | CUSIP: 92764N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    220000 | NS      | $1326600.00   | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| AnaptysBio Inc                                 | AnaptysBio Inc                                 | CUSIP: 032724106<br>LEI: 529900HH4WQT03IG1A12 | Long             | EC               | CORP              | US        |     93732 | NS      | $4544127.36   | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Illumina Inc                                   | Illumina Inc                                   | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |     90000 | NS      | $11804400.00  | 1.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Mustang Bio Inc                                | Mustang Bio Inc                                | CUSIP: 62818Q302<br>LEI: 5493004W0VC1DPECQ779 | Long             | EC               | CORP              | US        |       160 | NS      | $156.96       | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunovant Inc                                 | Immunovant Inc                                 | CUSIP: 45258J102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    122100 | NS      | $3103782.00   | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| CVS Health Corp                                | CVS Health Corp                                | CUSIP: 126650100<br>LEI: 549300EJG376EN5NQE29 | Long             | EC               | CORP              | US        |     75000 | NS      | $5952000.00   | 0.86%             |  |  |  | No            |                  1 | On Loan: No      |
| SIO GENE THERAPIES INC                         | SIO GENE THERAPIES INC                         | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     64171 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| Fannie Mae                                     | Federal National Mortgage Association          | CUSIP: 313586109<br>LEI: B1V7KEBTPIMZEU4LTD58 | Long             | EC               | USGSE             | US        |   1300000 | NS      | $13949000.00  | 2.01%             |  |  |  | No            |                  1 | On Loan: No      |
| AMBIT BIOSCIENCES CORP CVR                     | AMBIT BIOSCIENCES CORP CVR                     | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     76500 | NS      | $0.00         | 0.00%             |  |  |  | Yes           |                  3 | On Loan: No      |
| Vertex Pharmaceuticals Inc                     | Vertex Pharmaceuticals Inc                     | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |     25000 | NS      | $11334000.00  | 1.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Goldman Sachs Financial Square Government Fund | Goldman Sachs Financial Square Government Fund | CUSIP: 38141W273<br>LEI: 549300BRJMXN4GUWZ402 | Long             | STIV             | RF                | US        |    166516 | NS      | $166516.34    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Syndax Pharmaceuticals Inc                     | Syndax Pharmaceuticals Inc                     | CUSIP: 87164F105<br>LEI: 529900OF94TRHKZVBS87 | Long             | EC               | CORP              | US        |    180000 | NS      | $3781800.00   | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| Dynavax Technologies Corp                      | Dynavax Technologies Corp                      | CUSIP: 268158201<br>LEI: 549300T5URIXWDILX594 | Long             | EC               | CORP              | US        |    570000 | NS      | $8766600.00   | 1.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Halozyme Therapeutics Inc                      | Halozyme Therapeutics Inc                      | CUSIP: 40637H109<br>LEI: 529900242I3SV9AGM753 | Long             | EC               | CORP              | US        |    220000 | NS      | $14806000.00  | 2.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc                            | Gilead Sciences Inc                            | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |    210000 | NS      | $25775400.00  | 3.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals Inc                  | Regeneron Pharmaceuticals Inc                  | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |     47000 | NS      | $36277890.00  | 5.23%             |  |  |  | No            |                  1 | On Loan: No      |
| BioNTech SE                                    | BioNTech SE                                    | CUSIP: 09075V102<br>LEI: 894500UZJ5LG1F8J1U58 | Long             | EC               | CORP              | DE        |     18000 | NS      | $1713600.00   | 0.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Phio Pharmaceuticals Corp                      | Phio Pharmaceuticals Corp                      | CUSIP: 71880W501<br>LEI: 549300KOGMLSPLDVHR52 | Long             | EC               | CORP              | US        |     50000 | NS      | $52500.00     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Allogene Therapeutics Inc                      | Allogene Therapeutics Inc                      | CUSIP: 019770106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    146779 | NS      | $201087.23    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| MSILF Government Portfolio                     | MSILF Government Portfolio                     | CUSIP: 61747C707<br>LEI: 549300BI6Y5SI6BYPB26 | Long             | STIV             | RF                | US        |    166516 | NS      | $166516.34    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Stryker Corp                                   | Stryker Corp                                   | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |     15000 | NS      | $5272050.00   | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| InnoCare Pharma Ltd                            | InnoCare Pharma Ltd                            | CUSIP: 000000000<br>LEI: 3003001NYJPPWIEOJT79 | Long             | EC               | CORP              | CN        |     17000 | NS      | $26886.98     | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| Karyopharm Therapeutics Inc                    | Karyopharm Therapeutics Inc                    | CUSIP: 48576U205<br>LEI: 549300J1VANRCNTYST87 | Long             | EC               | CORP              | US        |     33333 | NS      | $245330.88    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Moderna Inc                                    | Moderna Inc                                    | CUSIP: 60770K107<br>LEI: 549300EI6OKH5K5Q2G38 | Long             | EC               | CORP              | US        |     20000 | NS      | $589800.00    | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-02-25

**Name of Applicant:** Delaware Group Equity Funds IV

**Signature:** Dan Geatens

**Name of Signer:** Dan Geatens

**Title:** Division Director - Head of US Fund Administration